ControversiesChallengesConsensus

CX 2019: NICE AAA guidelines under the spotlight

2019-02-18T10:22:42+00:00


The publication of the draft aortic guidelines by the National Institute for Health and Care Excellence (NICE) in May 2018 raised quite a stir.

However, the story is not over. In a CX Special Session, new analysis will show what we now know about long-term EVAR outcomes, and the vascular community’s concerns over the […]

CX 2019: NICE AAA guidelines under the spotlight2019-02-18T10:22:42+00:00

CX 2019: The last word on the paclitaxel controversy

2019-02-07T17:15:34+00:00

Since the publication of Katsanos et al’s meta-analysis in the Journal of the American Heart Association (JAHA), the science and support for paclitaxel-releasing devices in the legs is an unfolding story.

A CX 2019 Highlight session will feature two hours of independent review of the data and in-depth debate and discussion.

CX […]

CX 2019: The last word on the paclitaxel controversy2019-02-07T17:15:34+00:00

CX Symposium provides “ideal opportunity” to share your research

2018-08-16T16:44:15+00:00

In this interview, Meryl Davis, chair of the CX Abstract Board, talks about the benefits of presenting research at the CX Symposium and the importance of CX as a “global village”.

The CX Abstract Board is calling for senior and trainee doctors in the vascular and endovascular field to submit their […]

CX Symposium provides “ideal opportunity” to share your research2018-08-16T16:44:15+00:00

Present your abstract at CX 2019!

2018-11-02T12:54:03+00:00

The CX Abstract Board is calling for senior and trainee doctors in the vascular and endovascular field to submit their abstracts for presentation at the Charing Cross Symposium (15–18 April 2019, London, UK).

The best abstract presentation in each category (senior and trainee) will be awarded £1,000 and […]

Present your abstract at CX 2019!2018-11-02T12:54:03+00:00

CX 2018: Podium 1st presentations

2018-06-22T10:13:35+00:00

In addition to the plethora of late-breaking trials that were unveiled at this year’s Symposium, there was a vast array of Podium 1st presentations. These presentations showcased novel techniques and technologies, provided further insights into the safety and effectiveness of established devices, and highlighted potential solutions to current challenges in the management of vascular disease.

Peripheral […]

CX 2018: Podium 1st presentations2018-06-22T10:13:35+00:00

CX Abstract and Poster Prize winners announced!

2018-06-12T17:05:02+00:00

Poster prize winner Wei-Wen Ang with CX Abstract Board and Poster member Anna Prent

At CX 2018, abstracts were presented—across 17 sessions—on the five programme areas of CX: Acute stroke, Thoracic Aortic Abdominal Aortic, Peripheral, Venous, and Vascular Access. Additionally, throughout the symposium, delegates had the opportunity […]

CX Abstract and Poster Prize winners announced!2018-06-12T17:05:02+00:00

CX 2018 in numbers

2019-02-11T20:01:18+00:00

CX 2018 in numbers

This year’s CX welcomed more than 4,000 participants at Olympia London from a record-breaking 86 countries.

A leader of innovation, CX 2018 hosted a record-breaking 71 exhibitors and 15 new product launches—similar numbers are expected for CX 2019.

See the full stats and highlights in the video above.

CX 2018 in numbers2019-02-11T20:01:18+00:00

CX showcases most promising vascular innovations

2018-12-07T16:06:36+00:00

CX 2018 Dragons’ Den winner, Kieran Murphy, with the Dragons

The Innovation Showcase yesterday brought together the CX values of education, innovation, and evidence to paint a global picture of vascular entrepreneurship, highlighting the controversies currently threatening the next generation of game-changing products.

Beginning the […]

CX showcases most promising vascular innovations2018-12-07T16:06:36+00:00

One-year outcomes of EndoAnchor study adds ESAR—endosuture aneurysm repair—to the endovascular lexicon

2018-04-27T10:01:22+00:00

Frank Arko

Frank Arko (Charlotte, USA) presented one-year results from the 70-patient short-neck cohort of the ANCHOR Registry. Patients were treated with an endograft and endoanchors (Endurant and Heli-FX, Medtronic) for abdominal aortic aneurysm. The data showed “very good clinical outcomes in a challenging patient population”, Arko […]

One-year outcomes of EndoAnchor study adds ESAR—endosuture aneurysm repair—to the endovascular lexicon2018-04-27T10:01:22+00:00

Low early mortality and high technical success for novel thoracic stent graft

2018-04-27T10:33:59+00:00

A physician-sponsored investigational device exemption trial on thoracic endovascular aortic repair (TEVAR) using a new thoracic stent graft (Valiant thoracoabdominal aortic aneurysm stent graft, Medtronic), along with its initial 30-day data, was revealed at a Podium 1st presentation at CX 2018 by Thomas Maldonado (New York, USA). […]

Low early mortality and high technical success for novel thoracic stent graft2018-04-27T10:33:59+00:00

First case experience presented with next generation conformable EVAR device

2018-04-27T09:29:05+00:00

CX delegates were presented data from the first 10 EVAR patients treated using a new conformable device, the Gore Excluder conformable abdominal aortic aneurysm endoprosthesis with active control system, yesterday.

Robert Rhee (Brooklyn, New York), the national principal investigator of the US investigational device exemption (IDE) trial for […]

First case experience presented with next generation conformable EVAR device2018-04-27T09:29:05+00:00

“Fantastic” live case demonstrates potential value of intravascular lithotripsy

2018-04-27T09:56:24+00:00

In an exciting session yesterday, the CX audience witnessed the demonstration of a novel treatment strategy with intravascular lithotripsy for calcified arterial stenosis. It will now become a CX tradition to feature live cases to showcase what has been discussed in the presentations, so that the audience […]

“Fantastic” live case demonstrates potential value of intravascular lithotripsy2018-04-27T09:56:24+00:00

Live cases to illustrate the data: The future of the Charing Cross Symposium

2018-04-27T09:06:25+00:00

In yesterday’s plenary programmes, the future of the Charing Symposium was launched with the initiation of live case demonstrations to illustrate key data discussed on the programme. This year, both the Thoracic Aortic programme and the Peripheral Critical Ischaemia programme featured these illuminating cases, which stirred discussion and […]

Live cases to illustrate the data: The future of the Charing Cross Symposium2018-04-27T09:06:25+00:00

STEP seeks to advance patient safety after TEVAR

2018-04-27T10:06:45+00:00

Stroke is a major concern following TEVAR (thoracic endovascular aortic repair) and Charing Cross delegates heard the results from a collaborative study that pooled practice data from a number of high-volume centres in order to benefit patients undergoing the procedure. A highlight of the session was the […]

STEP seeks to advance patient safety after TEVAR2018-04-27T10:06:45+00:00

“Promising” initial results for sirolimus-eluting bioresorbable scaffold in DESappear trial

2018-04-25T11:15:59+00:00

DESappear Andrew Holden

The sirolimus-eluting bioresorbable peripheral scaffold system (Prava; Elixir Medical) is designed to treat stenoses and occlusion in the superficial femoral artery. Prava was first implanted in October 2016 and will be clinically evaluated in the DESappear trial that has currently enrolled 21 patients at 11 […]

“Promising” initial results for sirolimus-eluting bioresorbable scaffold in DESappear trial2018-04-25T11:15:59+00:00

CX 2018: Landmark EVRA trial provides first Level 1 evidence for early endovenous ablation

2018-04-25T10:25:09+00:00

EVRA

The first full results of the Early Venous Reflux Ablation (EVRA) ulcer study were presented at the Charing Cross Symposium yesterday. The presentation was accompanied by simultaneous publication in the New England Journal of Medicine after the session.

The randomised trial revealed that early endovenous ablation outperforms deferred […]

CX 2018: Landmark EVRA trial provides first Level 1 evidence for early endovenous ablation2018-04-25T10:25:09+00:00

Majority of CX audience decides endovascular-first strategy for critical limb ischaemia is a concept without evidence

2018-04-25T10:26:13+00:00

cx great debate
At the CX Great Debate held yesterday, vascular and endovascular surgery titans went head-to-head to debate the contentious topic “Endovascular-first strategy for critical limb ischaemia is a concept without evidence”. Arguing in favour of this motion were current Society for Vascular Surgery (SVS) president Clement […]

Majority of CX audience decides endovascular-first strategy for critical limb ischaemia is a concept without evidence2018-04-25T10:26:13+00:00

Drug-coated balloon is “highly effective and safe” and shows outstanding clinical improvement for patients compared to an uncoated balloon

2018-04-25T10:49:59+00:00

effpac Ulf Teichgraeber

The 12-month results from the full clinical cohort of the EffPAC randomised controlled trial, were presented for the first time at the CX Symposium yesterday.

Target lesion revascularisation at 12 months was 1.3% (vs 17.7% in the plain angioplasty group, p<0.001). Primary patency at 12 months […]

Drug-coated balloon is “highly effective and safe” and shows outstanding clinical improvement for patients compared to an uncoated balloon2018-04-25T10:49:59+00:00

Paclitaxel-eluting stent fails BATTLE against bare metal stent

2018-04-25T10:29:09+00:00

Yann Gouëffic

The BATTLE trial comparing a drug-eluting stent (Zilver PTX, Cook) vs. a bare metal stent (Misago, Terumo) for the treatment of intermediate femoropopliteal lesions has failed to the show superiority of the paclitaxel-coated stent at one-year follow-up. The trial highlights a need for further direct […]

Paclitaxel-eluting stent fails BATTLE against bare metal stent2018-04-25T10:29:09+00:00

EVRA (Early Venous Reflux Ablation) Ulcer Trial presented for the first time at the Charing Cross Symposium

2018-04-24T15:50:47+00:00

Alun Davies, EVRA chief investigator
Imperial College, London, United Kingdom

EVRA (Early Venous Reflux Ablation) Ulcer Trial presented for the first time at the Charing Cross Symposium2018-04-24T15:50:47+00:00

CX 2018: Record number of hands-on workshop opportunities for those technical tips and tricks!

2018-04-12T09:59:40+00:00

This year, there are four CX Workshops that offer a record number of hands-on workshop opportunities for those technical tips and tricks. The CX Venous Workshop—which has now been running for 10 years—has more than 80 workstations over two days. Last year, a staggering 1,100 people attended this workshop. Located in the Venous City, […]

CX 2018: Record number of hands-on workshop opportunities for those technical tips and tricks!2018-04-12T09:59:40+00:00

CX@CEC: Focus on challenging aortic disease

2018-04-03T17:25:30+00:00

Rodney White

This year’s annual China Endovascular Course (CEC; 2–5 November, Beijing, China) played host to the first CX@CEC session, in collaboration with the Charing Cross Symposium. Focused on complex aortic disease, this session featured a selection of international and Chinese experts sharing […]

CX@CEC: Focus on challenging aortic disease2018-04-03T17:25:30+00:00

CX 2018: Acute Stroke to explore the greatest carotid controversies of the day

2018-03-27T17:26:38+00:00

Ross Naylor at CX 2017

CX 2018 will close with the Acute Stroke CONTROVERSIES programme, which Ross Naylor—a member of the CX Programme Organising Board—promises will be a memorable session. The highlight will be five debates that will address a few “sacred cows” that arouse considerable controversy around […]

CX 2018: Acute Stroke to explore the greatest carotid controversies of the day2018-03-27T17:26:38+00:00

CX 2018: 40 Years of Looking Forward with vascular education as it should be!

2018-03-23T18:01:07+00:00

This year, CX celebrates 40 Years of Looking Forward. In this video, members of the CX Programme Organising Board and the CX Faculty explain why CX is not only unique but also provides vascular education “as it should be”! Register now for CX 2018!

CX 2018: 40 Years of Looking Forward with vascular education as it should be!2018-03-23T18:01:07+00:00